• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用毛细管 Western 免疫检测法,在 Becker 型肌营养不良症中,肌肉之间的 dystrophin 变异性低,且随时间稳定表达。

Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay.

机构信息

Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.

BioMarin Nederland BV, Leiden, The Netherlands.

出版信息

Sci Rep. 2021 Mar 15;11(1):5952. doi: 10.1038/s41598-021-84863-w.

DOI:10.1038/s41598-021-84863-w
PMID:33723284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7971009/
Abstract

Becker muscular dystrophy (BMD) is the milder allelic variant of Duchenne muscular dystrophy, with higher dystrophin levels. To anticipate on results of interventions targeting dystrophin expression it is important to know the natural variation of dystrophin expression between different muscles and over time. Dystrophin was quantified using capillary Western immunoassay (Wes) in the anterior tibial (TA) muscle of 37 BMD patients. Variability was studied using two samples from the same TA biopsy site in nine patients, assessing nine longitudinal TA biopsies, and eight simultaneously obtained vastus lateralis (VL) muscle biopsies. Measurements were performed in duplicate with two primary antibodies. Baseline dystrophin levels were correlated to longitudinal muscle strength and functional outcomes. Results showed low technical variability and high precision for both antibodies. Dystrophin TA levels ranged from 4.8 to 97.7%, remained stable over a 3-5 year period, and did not correlate with changes in longitudinal muscle function. Dystrophin levels were comparable between TA and VL muscles. Intra-muscle biopsy variability was low (5.2% and 11.4% of the total variability of the two antibodies). These observations are relevant for the design of clinical trials targeting dystrophin production, and may urge the need for other biomarkers or surrogate endpoints.

摘要

贝克肌营养不良症(BMD)是杜氏肌营养不良症的轻度等位基因变异,其肌营养不良蛋白水平较高。为了预测针对肌营养不良蛋白表达的干预措施的结果,了解不同肌肉之间以及随时间推移肌营养不良蛋白表达的自然变化非常重要。使用毛细管 Western 免疫分析(Wes)在 37 名 BMD 患者的胫骨前肌(TA)中定量肌营养不良蛋白。在 9 名患者中使用来自同一 TA 活检部位的两个样本研究了变异性,评估了 9 个纵向 TA 活检和 8 个同时获得的股外侧肌(VL)肌肉活检。使用两种主要抗体进行了两次重复测量。基线肌营养不良蛋白水平与纵向肌肉力量和功能结果相关。结果表明,两种抗体的技术变异性低且精度高。TA 肌营养不良蛋白水平范围为 4.8%至 97.7%,在 3-5 年内保持稳定,与纵向肌肉功能的变化无关。TA 和 VL 肌肉中的肌营养不良蛋白水平相当。肌肉内活检变异性较低(两种抗体总变异性的 5.2%和 11.4%)。这些观察结果与针对肌营养不良蛋白产生的临床试验设计相关,可能需要其他生物标志物或替代终点。

相似文献

1
Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay.使用毛细管 Western 免疫检测法,在 Becker 型肌营养不良症中,肌肉之间的 dystrophin 变异性低,且随时间稳定表达。
Sci Rep. 2021 Mar 15;11(1):5952. doi: 10.1038/s41598-021-84863-w.
2
Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy.毛细管 Western 免疫分析(Wes)在定量健康对照者和贝克型和杜氏肌营养不良症个体骨骼肌中的抗肌萎缩蛋白水平中的应用。
PLoS One. 2018 Apr 11;13(4):e0195850. doi: 10.1371/journal.pone.0195850. eCollection 2018.
3
Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.杜兴氏和贝克氏肌营养不良症肌肉活检中肌养蛋白水平与抗肌萎缩蛋白复合体及肌纤维再生的相关性
PLoS One. 2016 Mar 14;11(3):e0150818. doi: 10.1371/journal.pone.0150818. eCollection 2016.
4
A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.一种新型高通量免疫荧光分析方法,用于定量分析杜氏肌营养不良症肌肉活检样本整个横切面上的抗肌萎缩蛋白强度。
PLoS One. 2018 Mar 26;13(3):e0194540. doi: 10.1371/journal.pone.0194540. eCollection 2018.
5
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.Becker 型肌营养不良症中抗肌萎缩蛋白的定量检测及其与临床的相关性:对临床试验的影响。
Brain. 2011 Dec;134(Pt 12):3547-59. doi: 10.1093/brain/awr291. Epub 2011 Nov 18.
6
Development and Validation of a Western Blot Method to Quantify Mini-Dystrophin in Human Skeletal Muscle Biopsies.开发和验证一种用于定量检测人骨骼肌活检标本中微小肌营养不良蛋白的 Western blot 方法。
AAPS J. 2022 Dec 20;25(1):12. doi: 10.1208/s12248-022-00776-0.
7
Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.杜兴氏和贝克氏肌肉营养不良症携带者的肌营养不良蛋白分析。
Neurology. 2005 Dec 27;65(12):1984-6. doi: 10.1212/01.wnl.0000188909.89849.59.
8
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.mdx和dko营养不良小鼠以及杜氏肌营养不良症患者骨骼肌中Notch信号通路的改变。
Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17.
9
Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment.通过蛋白酶体抑制剂治疗对杜兴氏和贝克氏骨骼肌外植体中肌营养不良蛋白-糖蛋白复合物进行药理学挽救。
Am J Physiol Cell Physiol. 2006 Feb;290(2):C577-82. doi: 10.1152/ajpcell.00434.2005. Epub 2005 Sep 28.
10
High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients.高通量数字图像分析揭示了不同杜氏肌营养不良症患者中肌营养不良蛋白表达的独特模式。
J Neuropathol Exp Neurol. 2021 Oct 26;80(10):955-965. doi: 10.1093/jnen/nlab088.

引用本文的文献

1
Sensitivity of Different Clinical Outcome Measures in Assessing Adults With Becker Muscular Dystrophy: A 3-Year Natural History Study.不同临床结局指标在评估贝克型肌营养不良症成人患者中的敏感性:一项为期3年的自然史研究
Neurology. 2025 Oct 7;105(7):e214071. doi: 10.1212/WNL.0000000000214071. Epub 2025 Sep 5.
2
Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS/MS.通过数据非依赖采集液相色谱-串联质谱法对比贝克型和杜兴氏肌营养不良症的血清生物标志物候选物。
Skelet Muscle. 2025 Jun 7;15(1):15. doi: 10.1186/s13395-025-00385-3.
3
Advances in Duchenne Muscular Dystrophy: Diagnostic Techniques and Dystrophin Domain Insights.

本文引用的文献

1
Decision-Making And Selection Bias in Four Observational Studies on Duchenne and Becker Muscular Dystrophy.在四项关于杜氏和贝克型肌营养不良症的观察性研究中决策和选择偏倚。
J Neuromuscul Dis. 2020;7(4):433-442. doi: 10.3233/JND-200541.
2
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.Viltolarsen 治疗可进行外显子 53 跳跃的杜氏肌营养不良症男孩的安全性、耐受性和疗效:一项 2 期随机临床试验。
JAMA Neurol. 2020 Aug 1;77(8):982-991. doi: 10.1001/jamaneurol.2020.1264.
3
Muscle biopsies in clinical trials for Duchenne muscular dystrophy - Patients' and caregivers' perspective.
杜兴氏肌肉营养不良症的进展:诊断技术与肌营养不良蛋白结构域见解
Int J Mol Sci. 2025 Apr 10;26(8):3579. doi: 10.3390/ijms26083579.
4
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease.行业指南草案:杜氏肌营养不良症、贝克肌营养不良症和相关肌营养不良症——为整个疾病谱开发潜在的治疗方法。
J Neuromuscul Dis. 2024;11(2):499-523. doi: 10.3233/JND-230219.
5
Diffusion-tensor magnetic resonance imaging captures increased skeletal muscle fibre diameters in Becker muscular dystrophy.弥散张量磁共振成像显示贝克型肌营养不良症患者骨骼肌纤维直径增大。
J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1546-1557. doi: 10.1002/jcsm.13242. Epub 2023 May 1.
6
Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy.用于杜氏肌营养不良症的下一代外显子 51 跳跃反义寡核苷酸。
Nucleic Acid Ther. 2023 Jun;33(3):193-208. doi: 10.1089/nat.2022.0063. Epub 2023 Apr 10.
7
Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy.贝克型肌营养不良症监测生物标志物肌酸激酶、肌酸/肌酐和肌肉生长抑制素的纵向评估。
Neurology. 2023 Feb 28;100(9):e975-e984. doi: 10.1212/WNL.0000000000201609. Epub 2022 Dec 5.
8
Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials.微小肌营养不良蛋白表达作为杜氏肌营养不良症临床试验的替代终点。
Hum Gene Ther. 2023 May;34(9-10):404-415. doi: 10.1089/hum.2022.190. Epub 2023 Mar 14.
9
Development and Validation of a Western Blot Method to Quantify Mini-Dystrophin in Human Skeletal Muscle Biopsies.开发和验证一种用于定量检测人骨骼肌活检标本中微小肌营养不良蛋白的 Western blot 方法。
AAPS J. 2022 Dec 20;25(1):12. doi: 10.1208/s12248-022-00776-0.
10
Combining Protein Expression and Molecular Data Improves Mutation Characterization of Dystrophinopathies.结合蛋白质表达和分子数据可改善肌营养不良症的突变特征分析。
Front Neurol. 2021 Dec 7;12:718396. doi: 10.3389/fneur.2021.718396. eCollection 2021.
肌肉活检在杜氏肌营养不良症临床试验中的应用——患者和照护者的观点。
Neuromuscul Disord. 2019 Aug;29(8):576-584. doi: 10.1016/j.nmd.2019.06.004. Epub 2019 Jun 12.
4
Report of a TREAT-NMD/World Duchenne Organisation Meeting on Dystrophin Quantification Methodology.TREAT-NMD/世界杜氏肌营养不良组织肌营养不良蛋白定量方法学会议报告
J Neuromuscul Dis. 2019;6(1):147-159. doi: 10.3233/JND-180357.
5
Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production.依特司培生治疗杜氏肌营养不良症:外显子跳跃和抗肌萎缩蛋白的产生。
Neurology. 2018 Jun 12;90(24):e2146-e2154. doi: 10.1212/WNL.0000000000005680. Epub 2018 May 11.
6
Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy.毛细管 Western 免疫分析(Wes)在定量健康对照者和贝克型和杜氏肌营养不良症个体骨骼肌中的抗肌萎缩蛋白水平中的应用。
PLoS One. 2018 Apr 11;13(4):e0195850. doi: 10.1371/journal.pone.0195850. eCollection 2018.
7
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.杜氏肌营养不良症的诊断和管理,第 1 部分:诊断和神经肌肉、康复、内分泌、胃肠和营养管理。
Lancet Neurol. 2018 Mar;17(3):251-267. doi: 10.1016/S1474-4422(18)30024-3. Epub 2018 Feb 3.
8
Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.杜氏肌营养不良症的临床结局:来自 TREAT-NMD DMD 全球数据库的 5345 例患者研究。
J Neuromuscul Dis. 2017;4(4):293-306. doi: 10.3233/JND-170280.
9
Forty-Five Years of Duchenne Muscular Dystrophy in The Netherlands.荷兰杜氏肌营养不良症45年研究历程
J Neuromuscul Dis. 2014;1(1):99-109.
10
Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies.贝克型肌营养不良症的功能变化:对肌营养不良症中抗肌萎缩蛋白病临床试验的影响。
Sci Rep. 2016 Sep 1;6:32439. doi: 10.1038/srep32439.